12-month clinical results of a novel micro-interventional bio-stenting procedure published in the British Journal of Ophthalmology
January 23, 2023 08:00 ET
|
Iantrek, Inc.
WHITE PLAINS, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Iantrek today announced the publication of 12-month clinical results of a novel bio-stenting procedure using the company’s microsurgical...
Olleyes, Inc. Achieves ISO Certification
January 12, 2023 09:00 ET
|
Olleyes
SUMMIT, N.J., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Olleyes, Inc. announced today that it has earned the International Organization for Standardization (ISO) 13485:2016 certification from SGS. The...
Dry Eye Products Global Market Report 2022: Rising Incidence of Condition Bolsters Growth
January 10, 2023 10:26 ET
|
Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Dry Eye Products Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Antibiotic Drops, Hormone Drops, Artificial Tears and...
Dry Eye Products Global Market Report 2022: Rising Incidence of Condition Bolsters Growth
January 10, 2023 10:24 ET
|
Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Dry Eye Products Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Antibiotic Drops, Hormone Drops, Artificial Tears and...
Diabetic Macular Edema Treatment Global Market Report 2022: Intravitreal Implants Set to Take Center Stage
January 10, 2023 07:13 ET
|
Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Diabetic Macular Edema Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
Provectus Biopharmaceuticals Releases 2023 Stockholder Letter
January 09, 2023 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that it had issued a beginning-of-the-year letter for 2023 to the Company’s stockholders, which may be found...
Amber Ophthalmics Announces Positive Topline Phase 2 Data Evaluating NEXAGON® for the Treatment of Persistent Corneal Epithelial Defect (PCED)
January 09, 2023 07:31 ET
|
Amber Ophthalmics, Inc.
SAN DIEGO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Amber Ophthalmics, Inc. (Amber), a privately held clinical-stage biopharmaceutical company focused on developing innovative therapies for rare ophthalmic...
Global Ophthalmology PACS Market Report to 2030 - Market Players are Involved in Advancing Technologies for Ophthalmic Care Driving Growth
December 27, 2022 05:18 ET
|
Research and Markets
Dublin, Dec. 27, 2022 (GLOBE NEWSWIRE) -- The "Ophthalmology PACS Market, by Type, by Delivery Model, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022-2030" report...
Eyenovia Aims to Revolutionize Ophthalmology Devices With Microdose Array Print (MAP) Technology
December 22, 2022 09:01 ET
|
Eyenovia
NEW YORK, Dec. 22, 2022 (GLOBE NEWSWIRE) -- While medical devices have seen incredible advancements over the last 100 years, ocular drug delivery systems have seen minimal progress; the standard eye...
Wilmington Eye Ophthalmic Surgeon Implants First-Ever Glaucoma Device in the Carolinas
December 21, 2022 11:00 ET
|
Wilmington Eye
WILMINGTON, N.C., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Today, Wilmington Eye announced Dr. Robert van der Vaart, a board-certified ophthalmic surgeon and glaucoma expert, has successfully implanted the...